AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 3

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.31 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020255Enclomiphene citrateGGPepsGGPE-2410-S2226PeptideMeter2025-Q198.304.0590.6Buyer-sourced0FAIL
AX-2025-019820KPVHomopeptideHOMO-2411-P5026VendorInvestigate2025-Q199.605.06104.9Buyer-sourced0PASS
AX-2025-019649GHRP-2TFCTFC-2502-D2333Janoshik2025-Q199.404.8993.8Buyer-sourced0PASS
AX-2025-018996HexarelinASYASY-{CAT}-1786PeptideMeter2025-Q199.394.13—Buyer-sourced0PASS
AX-2025-018639TirzepatideQSCQSC-2408-T5296Janoshik2025-Q199.625.07—Buyer-sourced0PASS
AX-2025-018513BPC-157WWBWWB-2502-F3190Janoshik2025-Q199.935.3594.0Buyer-sourced0PASS
AX-2025-018509SemaglutideWWBWWB-2501-K3141Nordanalyt2025-Q198.294.0195.8Buyer-sourced1MARGINAL
AX-2025-021167SemaglutidePPGPPG-2408-B6709Janoshik2025-Q198.964.78100.9Supplier-supplied0PASS
AX-2025-021149RetatrutideSIGSIG-2411-6312Kestrel2025-Q197.333.5493.6Buyer-sourced0PASS
AX-2025-020299TB-500GGPepsGGPE-2501-B2246Janoshik2025-Q198.964.38—Buyer-sourced0PASS
AX-2025-020005RetatrutideSWBSWB-2411-R7167Janoshik2025-Q197.863.92—Buyer-sourced0PASS
AX-2025-019902TirzepatideHJHJ-2501-P5963Janoshik2025-Q198.752.43—Buyer-sourced0PASS
AX-2025-019532IpamorelinTFCTFC-2408-T9161Nordanalyt2025-Q199.113.84—Buyer-sourced0PASS
AX-2025-018819L-CarnosineFGPFGP-2501-G8414PeptideMeter2025-Q199.568.59—Buyer-sourced0PASS
AX-2025-018748CJC-1295 (no DAC)QSCQSC-2411-D7855PeptideMeter2025-Q199.074.26—Buyer-sourced0PASS
AX-2025-018743CJC-1295 (no DAC)QSCQSC-2411-D7855Kestrel2025-Q199.674.21—Buyer-sourced0PASS
AX-2025-018515SemaglutideWWBWWB-2410-J3284Medutest2025-Q199.932.8790.6Buyer-sourced0PASS
AX-2025-021181SS-31 (Elamipretide)PPGPPG-2411-D6795Janoshik2025-Q199.845.2997.7Buyer-sourced0PASS
AX-2025-021173SS-31 (Elamipretide)PPGPPG-2411-D6795PeptideMeter2025-Q199.425.92—Laboratory-retained0PASS
AX-2025-021171SS-31 (Elamipretide)PPGPPG-2411-D6795Janoshik2025-Q199.765.3595.8Laboratory-retained0PASS
AX-2025-020949BPC-157WXTWXT-2501-J3079Nordanalyt2025-Q198.785.91101.3Buyer-sourced0PASS
AX-2025-020259Enclomiphene citrateGGPepsGGPE-2410-S2226Medutest2025-Q198.944.0298.6Supplier-supplied0FAIL
AX-2025-019953TB-500HJHJ-2501-A6454Janoshik2025-Q199.934.67105.4Supplier-supplied1MARGINAL
AX-2025-019821KPVHomopeptideHOMO-2411-P5026Janoshik2025-Q199.484.6288.6Buyer-sourced1FAIL
AX-2025-019190CJC-1295 with DACSinoPepSNP-2412-E4702VendorInvestigate2025-Q198.442.59105.2Buyer-sourced0PASS
AX-2025-018579SemaglutideQYBQYB-2410-V4909PeptideMeter2025-Q199.353.54106.0Buyer-sourced0PASS
AX-2025-018524AfamelanotideWWBWWB-2408-E4076Nordanalyt2025-Q199.271.74105.7Buyer-sourced0PASS
AX-2025-020497SermorelinKPKP-2501-V5712Janoshik2025-Q198.835.64—Buyer-sourced1MARGINAL
AX-2025-020312CJC-1295 (no DAC)GGPepsGGPE-2408-G2525Janoshik2025-Q198.433.36105.9Buyer-sourced0PASS
AX-2025-019942AOD-9604HJHJ-2502-E7144Janoshik2025-Q198.441.77—Buyer-sourced0PASS
AX-2025-019785Melanotan IIHomopeptideHOMO-2502-H4892Janoshik2025-Q199.933.04107.0Buyer-sourced1FAIL
AX-2025-019777BPC-157HomopeptideHOMO-2411-K4425VendorInvestigate2025-Q199.923.68—Buyer-sourced0PASS
AX-2025-018902RetatrutideTFSTFS-{CAT}-9723Nordanalyt2025-Q198.845.11103.6Buyer-sourced0PASS
AX-2025-018830BPC-157FGPFGP-2409-Y8596Janoshik2025-Q199.595.44—Buyer-sourced0PASS
AX-2025-018471TirzepatideWWBWWB-2502-U2990Janoshik2025-Q198.843.5689.4Buyer-sourced2MARGINAL
AX-2025-021133EpitalonSIGSIG-2412-6325PeptideMeter2025-Q199.528.24—Buyer-sourced0PASS
AX-2025-020900MK-677 (Ibutamoren mesylate)WXTWXT-2502-F2050PeptideMeter2025-Q199.484.3390.2Buyer-sourced0FAIL
AX-2025-020766SemaglutideSGNSGN-2410-D9265VendorInvestigate2025-Q197.834.95—Buyer-sourced0PASS
AX-2025-019892TirzepatideHJHJ-2501-P5963PeptideMeter2025-Q198.291.9393.0Buyer-sourced0PASS
AX-2025-019800L-Glutathione (reduced)HomopeptideHOMO-2501-D4371Janoshik2025-Q199.739.22—Buyer-sourced0PASS